Pelthos Therapeutics Inc.
PTHS
$26.90
$0.602.28%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.24M | -21.66M | -16.24M | -3.45M | -1.97M |
| Total Depreciation and Amortization | 1.57M | 1.22M | 1.14M | -- | -- |
| Total Amortization of Deferred Charges | 195.00K | 0.00 | 100.00 | 164.70K | 94.00K |
| Total Other Non-Cash Items | -2.22M | 18.41M | 4.87M | 413.50K | 486.00K |
| Change in Net Operating Assets | -2.44M | -4.22M | -5.03M | 2.42M | 756.00K |
| Cash from Operations | -13.13M | -6.25M | -15.26M | -447.10K | -632.00K |
| Capital Expenditure | -194.00K | -99.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -7.90M | 2.76M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -194.00K | -8.00M | 2.76M | -- | -- |
| Total Debt Issued | 29.34M | 17.90M | 68.00K | 375.00K | 250.00K |
| Total Debt Repaid | -1.81M | 0.00 | -845.00K | -- | -- |
| Issuance of Common Stock | -- | 121.00K | 85.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 27.38M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.52M | 18.02M | 26.69M | 375.00K | 250.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.20M | 3.77M | 14.19M | -72.10K | -382.00K |